LENNOX-GASTAUT SYNDROME (LGS)
Clinical trials for LENNOX-GASTAUT SYNDROME (LGS) explained in plain language.
Never miss a new study
Get alerted when new LENNOX-GASTAUT SYNDROME (LGS) trials appear
Sign up with your email to follow new studies for LENNOX-GASTAUT SYNDROME (LGS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Smart brain implant adapts to Sleep-Wake cycles to fight seizures
Disease control Not yet recruitingThis early study tests a new deep brain stimulation (DBS) approach that adjusts stimulation based on whether the person is awake or asleep. Four adults with Lennox-Gastaut syndrome will receive a Medtronic Percept DBS device. Researchers will compare personalized day/night stimul…
Matched conditions: LENNOX-GASTAUT SYNDROME (LGS)
Phase: NA • Sponsor: University of Minnesota • Aim: Disease control
Last updated May 26, 2026 11:46 UTC
-
Study tests safer switch from homemade CBD to approved seizure drug
Disease control Not yet recruitingThis study looks at the best way to switch children with Dravet or Lennox-Gastaut syndrome from artisanal (non-pharmaceutical) cannabidiol to Epidiolex, an FDA-approved prescription drug for seizures. About 25 children aged 2 to 18 will gradually replace their artisanal CBD with …
Matched conditions: LENNOX-GASTAUT SYNDROME (LGS)
Phase: PHASE4 • Sponsor: Elizabeth Donner • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Wearable brain sensors aim to perfect seizure drug dosing at home
Knowledge-focused Not yet recruitingThis study tests whether a wearable home monitoring system (EEG, heart rate, breathing) helps doctors feel more confident when adjusting the dose of fenfluramine for people with Dravet or Lennox-Gastaut syndrome. Twenty patients aged 3 and up will wear the devices for 3–7 days at…
Matched conditions: LENNOX-GASTAUT SYNDROME (LGS)
Phase: NA • Sponsor: Byteflies • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC